Verified Nov 2026
Other
·

Zug, Canton of Zug
·
Since 2011
Covis Pharma is a specialty pharmaceutical company founded in 2011 and headquartered in Zug, Switzerland, with 200–500 employees and estimated annual revenue of $50–100 million. The company develops and markets therapeutic solutions for respiratory, allergy, oncology, cardiovascular, and gastrointestinal diseases across more than 50 countries. In March 2025, Azurity Pharmaceuticals acquired Covis Pharma from its existing investors.
Covis Pharma at a glance
Revenue
$50-100M
Est. band
Employees
200-500
Founded
2011
Headquarters
Zug, Canton of Zug
Industries
Automotive
Electric Vehicles
Medical
Industrial Equipment
Overview
Covis Pharma is a specialty pharmaceutical company founded in 2011 and headquartered in Zug, Switzerland, with 200–500 employees and estimated annual revenue of $50–100 million. The company develops and markets therapeutic solutions for respiratory, allergy, oncology, cardiovascular, and gastrointestinal diseases across more than 50 countries. In March 2025, Azurity Pharmaceuticals acquired Covis Pharma from its existing investors.
At a glance
Attribute | Detail |
|---|---|
Founded | 2011 |
Headquarters | Zug, Canton of Zug |
Employees | 200-500 |
Revenue | $50-100M (estimated) |
What Covis Pharma makes
The company markets branded pharmaceutical products including Alvesco for asthma, Omnaris and Zetonna for nasal allergies, and Eklira for COPD.
Products and capabilities described on the company's own site include LED (source: covispharma.com).
Latest developments
2026-03-12 — NAVLIN DAILY (navlindaily.com)
2025-03-19 — Reed Smith represents Covis Group on its acquisition by… (reedsmith.com)
2025-03-17 — Azurity acquires Covis Pharma from existing investors (pharmaceutical-technology.com)
2025-03-14 — Azurity Pharmaceuticals Completes Acquisition of Covis Pharma | Covis Pharma (covispharma.com)
2025-03-14 — News | Covis Pharma (covispharma.com)
2025-03-14 — Azurity Pharmaceuticals Acquires Covis Group | Contract Pharma (contractpharma.com)
Company details
Covis Pharma operates as a subsidiary of Azurity Pharmaceuticals following its acquisition and maintains regional hubs in Waltham, Massachusetts; Berkeley Heights, New Jersey; and Amsterdam, Netherlands. Covis Pharma was founded in 2011, has an estimated 200-500 employees, and is headquartered in Zug, Canton of Zug.
Frequently asked questions
What does Covis Pharma do?
Covis Pharma is a specialty pharmaceutical company founded in 2011 and headquartered in Zug, Switzerland, with 200–500 employees and estimated annual revenue of $50–100 million. The company develops and markets therapeutic solutions for respiratory, allergy, oncology, cardiovascular, and gastrointestinal diseases across more than 50 countries. In March 2025, Azurity Pharmaceuticals acquired Covis Pharma from its existing investors.
Where is Covis Pharma headquartered?
Covis Pharma is headquartered in Zug, Canton of Zug (12 Grafenauweg, Zug, Canton of Zug, 6300).
When was Covis Pharma founded?
Covis Pharma was founded in 2011.
How big is Covis Pharma?
Covis Pharma has an estimated 200-500 employees, with revenue in the $50-100M range (estimated).
Related suppliers
Explore other suppliers in the LightSource directory:
Last verified Nov 2026. Is this your company? Request a correction.
Location & contact
Evaluating suppliers like these?
This profile is part of a public-data sample of the full LightSource directory. Book a demo to see the full LightSource marketplace and supplier discovery platform — 1M+ credible suppliers, with AI-run sourcing events.
